These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15906378

  • 21. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
    Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S.
    Nature; 2009 Jun 25; 459(7250):1126-30. PubMed ID: 19458618
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
    Liu W, Zhou H, Liu L, Zhao C, Deng Y, Chen L, Wu L, Mandrycky N, McNabb CT, Peng Y, Fuchs PN, Lu J, Sheen V, Qiu M, Mao M, Lu QR.
    Neurobiol Dis; 2015 May 25; 77():106-16. PubMed ID: 25747816
    [Abstract] [Full Text] [Related]

  • 24. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.
    Fuentes JJ, Pritchard MA, Estivill X.
    Genomics; 1997 Sep 15; 44(3):358-61. PubMed ID: 9325060
    [Abstract] [Full Text] [Related]

  • 25. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE, Richtsmeier JT, Leszl J, Reeves RH.
    Science; 2004 Oct 22; 306(5696):687-90. PubMed ID: 15499018
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis.
    Casas C, Martínez S, Pritchard MA, Fuentes JJ, Nadal M, Guimerà J, Arbonés M, Flórez J, Soriano E, Estivill X, Alcántara S.
    Mech Dev; 2001 Mar 22; 101(1-2):289-92. PubMed ID: 11231093
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis.
    Seo DS, Chau GC, Baek KH, Um SH.
    Mol Metab; 2019 Mar 22; 21():82-89. PubMed ID: 30583978
    [Abstract] [Full Text] [Related]

  • 36. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
    Chan B, Greenan G, McKeon F, Ellenberger T.
    Proc Natl Acad Sci U S A; 2005 Sep 13; 102(37):13075-80. PubMed ID: 16131541
    [Abstract] [Full Text] [Related]

  • 37. Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.
    Kurabayashi N, Sanada K.
    Genes Dev; 2013 Dec 15; 27(24):2708-21. PubMed ID: 24352425
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Conotruncal anomalies in the trisomy 16 mouse: an immunohistochemical analysis with emphasis on the involvement of the neural crest.
    Waller BR, McQuinn T, Phelps AL, Markwald RR, Lo CW, Thompson RP, Wessels A.
    Anat Rec; 2000 Nov 01; 260(3):279-93. PubMed ID: 11066038
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.